| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.84B | +3.7% |
| Cost of Revenue | $1.79B | +5.3% |
| Gross Profit | $1.05B | +1.0% |
| R&D Expense | $44.0M | +12.2% |
| SG&A Expense | $608.4M | +4.9% |
| Operating Income | $412.2M | -7.9% |
| Pre-tax Income | $328.3M | -11.4% |
| Income Tax | $69.2M | -10.6% |
| Net Income | $226.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $185.9M | -25.5% |
| Accounts Receivable | $451.3M | +21.9% |
| Inventory | $481.8M | +19.3% |
| Current Assets | $1.26B | +9.9% |
| Total Assets | $4.77B | +18.1% |
| Current Liabilities | $664.8M | +5.2% |
| Long-term Debt | $1.23B | +16.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $260.6M | -26.7% |
| Capital Expenditures | $47.3M | -8.7% |
| Investing Cash Flow | -$479.9M | -133.3% |
| Financing Cash Flow | $113.7M | +259.0% |
| Free Cash Flow | $213.3M | -29.8% |
| -14.4% |
| EPS (Basic) | $3.71 | -14.9% |
| EPS (Diluted) | $3.67 | -14.8% |
| Total Liabilities |
| $2.55B |
| +14.8% |
| Stockholders' Equity | $2.17B | +22.4% |